SCHEMBL9905709

SCHEMBL9905709

COC(=O)c1cc(OC(C)Cc2ccccc2)c2c(c1)OC(C)(C)C2

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 2/20 0.40
TSHR P16473 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPGD P15428 1/20 0.39
NOX1 Q9Y5S8 1/20 0.38
KLK7 P49862 1/20 0.38
SLC7A5 Q01650 1/20 0.37
KMT2A Q03164 1/20 0.37
NPC1 O15118 2/20 0.36
MAOB P27338 1/20 0.36
GCK P35557 2/20 0.36
RARA P10276 1/20 0.36
RARB P10826 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL642146 1.00 RAB9A (0.40) RAB9ALMNASMN1; SMN2MAPTTSHR
SCHEMBL2644681 0.90 GCK (0.39) RAB9ASMN1; SMN2MAPTTSHRHPGD
SCHEMBL643693 0.85 LMNA (0.51) RAB9ALMNASMN1; SMN2MAPTTSHR
SCHEMBL2645432 0.82 LDHA (0.40) RAB9ALMNASMN1; SMN2MAPTHPGD
SCHEMBL644402 0.80 GCK (0.56) RAB9ANPC1GCKRARARARB
SCHEMBL642200 0.79 MAPT (0.41) RAB9ALMNASMN1; SMN2MAPTTSHR
SCHEMBL642767 0.79 MAPT (0.41) RAB9ALMNASMN1; SMN2MAPTTSHR
SCHEMBL2644915 0.78 GCK (0.36) HPGDGCKRARARARBFFAR4
SCHEMBL643590 0.74 MAOB (0.49) RAB9ASMN1; SMN2HPGDKMT2ANPC1
SCHEMBL642852 0.74 SCN9A (0.41) RAB9ALMNASMN1; SMN2MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463283-B1 Fused phenyl Amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases PFIZER PROD INC (US) 2014-06-11 EP disclosed
EP-2463283-A1 Fused phenyl Amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases Pfizer Products Inc. (US) 2012-06-13 EP disclosed